Mavens Biotech Ltd.
BSE: 590083 | Sector: Others |
NSE: N.A. | ISIN Code: INE856C01047 |
BSE 00:00 | 04 Mar | Mavens Biotech Ltd Not listed in BSE |
NSE 05:30 | 01 Jan | Mavens Biotech Ltd Not listed in NSE |
OPEN | 0.71 |
PREVIOUS CLOSE | 0.74 |
VOLUME | 25200 |
52-Week high | 0.74 |
52-Week low | 0.00 |
P/E | |
Mkt Cap.(Rs cr) | 8 |
Buy Price | 0.71 |
Buy Qty | 4800.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
About Mavens Biotech Ltd.
Mavens Biotech Limited was originally incorporated on 24th October 1981 and was initially involved in the trading of agricultural and related products.The company went public in the 1982 with 248000 equity shares at par. Out which 150000 equity shares were offered to the public and balance 98000 equity shares were reserved for Directors Promoters their friends relatives and associates.Equity capit...> More
Mavens Biotech Ltd - Key Fundamentals
Parameter | Values | ||
Market Cap | (![]() |
8 | |
EPS - TTM | (![]() |
[*S] | - |
P/E Ratio | (X) | [*S] | - |
Face Value | (![]() |
1 | |
Latest Dividend | (%) | 9.00 | |
Latest Dividend Date | 16 Sep 2010 | ||
Dividend Yield | (%) | 0.00 | |
Book Value / Share | (![]() |
[*S] | 0.52 |
P/B Ratio | (![]() |
[*S] | 1.42 |
Announcement
-
Board Meeting Intimation for Results & Closure of Trading Window
-
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations 2015 for Quarter ended D
-
Statement of deviation or variation for the quarter ended December 31 2016
-
Standalone Financial Results Limited Review Report for September 30 2016
-
Board Meeting Intimation for Results & Closure of Trading Window
-
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations 2015 for Quarter ended S
Mavens Biotech Ltd - Financial Results
Particulars (![]() |
Dec 2016 | Dec 2015 | % Chg |
Net Sales | 0.2 | 0.22 | -9.09 |
Other Income | - | ||
Total Income | 0.2 | 0.22 | -9.09 |
Total Expenses | 0.17 | 0.14 | 21.43 |
Operating Profit | 0.03 | 0.09 | -66.67 |
Net Profit | 0.01 | 0.05 | -80 |
Equity Capital | 10.99 | 10.99 | - |
Mavens Biotech Ltd - Peer Group
Company | Price(![]() |
Chg (%) | Mkt Cap (![]() |
Modella Woollens | 92.50 | -5.61 | 8.42 |
Mitshi India | 9.38 | -5.44 | 8.25 |
Swagtam Trading | 68.50 | -4.99 | 8.15 |
JMD Ventures | 5.48 | 1.86 | 7.91 |
Innovative Ideal | 6.54 | 0.00 | 7.44 |
Aayush Food&Herb | 22.50 | -4.05 | 7.31 |
Nexus Surgical | 12.61 | -4.47 | 6.90 |
Mavens Biotech Ltd - SHAREHOLDING PATTERN
|
|
Mavens Biotech Ltd - RETURNS
Period | BSE | NSE | Sensex | NIFTY |
1 Week | NA | NA | 0.34% | 0.34% |
1 Month | NA | NA | -4.47% | -4.66% |
3 Month | NA | NA | -10.74% | -10.86% |
6 Month | NA | NA | -9.18% | -9.23% |
1 Year | NA | NA | 1.13% | 0.46% |
3 Year | NA | NA | 33.31% | 32.75% |
Mavens Biotech Ltd - STOCK STRENGTH
Today's Low/High | 0.71 | 0.74 | |
Week Low/High | 0.00 | 0.74 | |
Month Low/High | 0.00 | 0.74 | |
YEAR Low/High | 0.00 | 0.74 | |
All TIME Low/High | 0.40 | 175.00 |
Quick Links for Mavens Biotech:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices